{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:14:19Z","timestamp":1791209659037,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","contactlensjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.clae.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T19:09:14Z","timestamp":1441393754000},"page":"2-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["On the prescribing of oral doxycycline or minocycline by UK optometrists as part of management of chronic Meibomian Gland Dysfunction (MGD)"],"prefix":"10.1016","volume":"39","author":[{"given":"Michael J.","family":"Doughty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clae.2015.08.002_bib0480","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1475-1313.1990.tb00968.x","article-title":"Meibomian gland dysfunction: some clinical, biochemical and physical observations","volume":"10","author":"Ong","year":"1990","journal-title":"Ophthal. Physiol. Opt."},{"key":"10.1016\/j.clae.2015.08.002_bib0485","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00003226-199503000-00005","article-title":"Meibomian gland dysfunction and tear film abnormalities in rosacea","volume":"14","author":"Zengin","year":"1995","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.08.002_bib0490","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6257(96)80064-6","article-title":"Meibomian gland dysfunction","volume":"40","author":"Driver","year":"1996","journal-title":"Surv. Ophthalmol."},{"issue":"Suppl","key":"10.1016\/j.clae.2015.08.002_bib0495","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ophtha.2012.06.064","article-title":"Improving awareness, identification and management of Meibomian gland dysfunction","volume":"119","author":"Foulks","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2015.08.002_bib0500","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/OPX.0b013e3182693cef","article-title":"Lid margins: sensitivity, staining, Meibomian Gland Dysfunction, and symptoms","volume":"89","author":"Golebiowski","year":"2012","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.clae.2015.08.002_bib0505","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jtos.2014.05.005","article-title":"Treatment of blepharitis: Recent clinical trials","volume":"12","author":"Pflugfelder","year":"2014","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.clae.2015.08.002_bib0510","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on Meibomian gland dysfunction: Report of the subcommittee on management and treatment of Meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clae.2015.08.002_bib0515","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1542-0124(12)70121-0","article-title":"Ocular rosacea","volume":"3","author":"Alvarenga","year":"2005","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.clae.2015.08.002_bib0520","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on Mebomian gland dysfunction: report of the subcommittee on anatomy, physiology and pathophysiology of the Meibomian glands","volume":"52","author":"Knop","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clae.2015.08.002_bib0525","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/bjo.45.11.718","article-title":"The Meibomian glands. An investigation into the secretion and some aspects of the physiology","volume":"45","author":"Linton","year":"1961","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0530","first-page":"2970","article-title":"The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci","volume":"32","author":"Dougherty","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clae.2015.08.002_bib0535","first-page":"97","article-title":"Standard management options for rosacea. Part 2: Options according to subtype","volume":"84","author":"Odom","year":"2009","journal-title":"Cutis"},{"key":"10.1016\/j.clae.2015.08.002_bib0540","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0545","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000235550","article-title":"Tetracycline actions relevant to rosacea treatment","volume":"22","author":"Korting","year":"2009","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.clae.2015.08.002_bib0550","doi-asserted-by":"crossref","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","article-title":"Tetracyclines: a pleotropic family of compounds with promising therapeutic properties. Review of the literature","volume":"299","author":"Griffin","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.clae.2015.08.002_bib0555","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.phrs.2011.06.013","article-title":"The non-antibiotic properties of tetracyclines: Clinical potential in ophthalmic disease","volume":"64","author":"Thomas","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.clae.2015.08.002_bib0560","first-page":"1067","article-title":"Non-medical prescribing","author":"British National Formulary","year":"2015","journal-title":"Optometrists"},{"key":"10.1016\/j.clae.2015.08.002_bib0565","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bjo.35.3.153","article-title":"Aureomycin borate in external ocular conditions","volume":"35","author":"McWilliams","year":"1951","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0570","series-title":"Monthly Index Medical Specialties","first-page":"245","author":"MIMS","year":"2015"},{"key":"10.1016\/j.clae.2015.08.002_bib0575","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/AAC.6.4.411","article-title":"Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and \u2013 resistant Staphylococci","volume":"6","author":"Minuth","year":"1974","journal-title":"Antimicrobial Agents Chemotherap."},{"key":"10.1016\/j.clae.2015.08.002_bib0580","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000221939","article-title":"Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycline, and minocycline with in vivo use","volume":"22","author":"Lewis","year":"1976","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clae.2015.08.002_bib0585","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/AAC.10.3.387","article-title":"Antimicrobial susceptibility of Propionibacterium acnes and related microbial species","volume":"10","author":"Hoeffler","year":"1976","journal-title":"Antimicrobial Agents Chemotherap."},{"key":"10.1016\/j.clae.2015.08.002_bib0590","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF01978919","article-title":"Metal ion-tetracycline interactions in biological fluids. Part. 3","volume":"14","author":"Lambs","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.clae.2015.08.002_bib0595","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0190-9622(85)80041-4","article-title":"Absorption of minocycline hydrochloride and tetracycline hydrochloride. Effect of food, milk, and iron","volume":"12","author":"Leyden","year":"1985","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0600","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01639529","article-title":"Influence of milk on the bioavailability of doxycycline \u2013 new aspects","volume":"17","author":"Meyer","year":"1989","journal-title":"Infection"},{"key":"10.1016\/j.clae.2015.08.002_bib0605","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/bdd.2510110202","article-title":"Absorption of doxycycline from a controlled release pellet formulation: the influence of food on bioavailability","volume":"11","author":"Williams","year":"1990","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.clae.2015.08.002_bib0610","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2165\/00003088-199018030-00003","article-title":"Effects of antacids on the clinical pharmacokinetics of drugs. An update","volume":"18","author":"Gugler","year":"1990","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.clae.2015.08.002_bib0615","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1358\/dot.2007.43.1.1025697","article-title":"Update on rosacea and anti-inflammatory-dose doxycycline","volume":"43","author":"Berman","year":"2007","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.clae.2015.08.002_bib0620","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1540-9740.2007.06460.x","article-title":"Anti-inflammatory dose doxycycline (40mg controlled-release) confers maximum anti-inflammatory efficacy in rosacea","volume":"6","author":"Theobald","year":"2007","journal-title":"Skinmed"},{"key":"10.1016\/j.clae.2015.08.002_bib0625","first-page":"1149","article-title":"Subantimicrobial-dose doxycycline in the treatment of moderate facial acne","volume":"7","author":"Toossi","year":"2008","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0630","first-page":"573","article-title":"Comparison of anti-inflammatory dose doxycycline versus doxycyclcine 100mg in the treatment of rosacea","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0635","first-page":"425","article-title":"Minocycline in the treatment of acne: latest findings","volume":"145","author":"Maffeis","year":"2010","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"10.1016\/j.clae.2015.08.002_bib0640","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1128\/AAC.05710-11","article-title":"Pharmacokinetics of doxycycline in adults with cystic fibrosis","volume":"56","author":"Beringer","year":"2012","journal-title":"Antimicrob. Agents Chemotherap."},{"key":"10.1016\/j.clae.2015.08.002_bib0645","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10557-008-6150-7","article-title":"Short-term effects of doxycycline on matrix metalloproteinases 2 and 9","volume":"23","author":"Fiotti","year":"2009","journal-title":"Cardiovasc. Drugs Chemotherap."},{"key":"10.1016\/j.clae.2015.08.002_bib0650","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/112067210901900504","article-title":"In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis","volume":"19","author":"Iovieno","year":"2009","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0655","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00417-005-0212-3","article-title":"Tear fluid levels of MMP-8 are elevated in ocular rosacea \u2013 treatment effect of oral doxycycline","volume":"244","author":"M\u00e4\u00e4tt\u00e4","year":"2006","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0660","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-9255-6-31","article-title":"Cleavage of functional IL-2 receptor alpha chain (CD 25) from murine corneal and conjunctival epithelial by MMP-9","volume":"6","author":"De Pavia","year":"2009","journal-title":"J. Inflamm."},{"key":"10.1016\/j.clae.2015.08.002_bib0665","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bjo.2003.025551","article-title":"Doxycycline \u2013 a role in ocular surface repair","volume":"88","author":"Smith","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0670","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1167\/iovs.13-11787","article-title":"Doxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts","volume":"54","author":"Li","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.clae.2015.08.002_bib0675","series-title":"Optometric Pharmacology and Therapeutics","first-page":"1","article-title":"Basic principles of pharmacology","author":"Doughty","year":"1991"},{"key":"10.1016\/j.clae.2015.08.002_bib0680","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/AAC.11.3.462","article-title":"Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects","volume":"11","author":"Welling","year":"1977","journal-title":"Antimicrob. Agents Chemotherap."},{"key":"10.1016\/j.clae.2015.08.002_bib0685","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000221802","article-title":"Serum concentration and urinary excretion of doxycycline in normal subjects and patients with renal insufficiency","volume":"20","author":"Ao","year":"1974","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clae.2015.08.002_bib0690","first-page":"1031","article-title":"Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function","volume":"103","author":"Mahon","year":"1970","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.clae.2015.08.002_bib0695","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2125.1983.tb02157.x","article-title":"The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man","volume":"16","author":"Houin","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.clae.2015.08.002_bib0700","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000238345","article-title":"Pharmacokinetics of lymecycline and doxycycline in serum and suction blister fluid","volume":"31","author":"Schreiner","year":"1985","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clae.2015.08.002_bib0705","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.clae.2015.08.002_bib0710","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4269\/ajtmh.2009.09-0214","article-title":"Sex affects the steady-state pharmacokinetics of primaquine but not doxycycline in healthy subjects","volume":"81","author":"Binh","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.clae.2015.08.002_bib0715","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000238249","article-title":"Bioavailability of doxycyline monohydrate. A comparison with equivalent doses of doxycycline hydrochloride","volume":"30","author":"Malmborg","year":"1984","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clae.2015.08.002_bib0720","first-page":"556","article-title":"In-vitro-Aktivit\u00e4t und Pharmakokinetik von Minocyclin","volume":"26","author":"Simon","year":"1976","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.clae.2015.08.002_bib0725","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archopht.1989.01070010095034","article-title":"Minocycline levels in tears of patients with active trachoma","volume":"107","author":"Tabbara","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0730","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/jech.54.2.143","article-title":"Accuracy of the estimated prevalence of obesity from self reported height and weight of an adult Scottish population","volume":"54","author":"Boulton-Smith","year":"2000","journal-title":"J. Epidemiol. Health"},{"key":"10.1016\/j.clae.2015.08.002_bib0735","first-page":"40","article-title":"Oral antibiotic therapy for acne vulgaris. Pharmacokinetic and pharmacodynamic perspectives","volume":"4","author":"Leyden","year":"2011","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0740","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1346-8138.1989.tb01282.x","article-title":"Absence of minocycline in sebum?","volume":"16","author":"Aubin","year":"1989","journal-title":"J. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0745","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.2007.125989","article-title":"Does orally administered doxycycline reach the tear film?","volume":"92","author":"Smith","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0750","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.2007.00932.x","article-title":"Pharmacokinetics of pradofloxacin and doxycline in serum, saliva, and tear fluid of cats after oral administration","volume":"31","author":"Hartmann","year":"2008","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.clae.2015.08.002_bib0755","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1463-5224.2008.00662.x","article-title":"Doxycycline levels in preocular tear film of horses following oral administration","volume":"11","author":"Baker","year":"2008","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0760","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2460\/ajvr.67.2.310","article-title":"Pharmacokinetics and tissue distribution of doxycyline after oral administration of single and multiple doses in horse","volume":"67","author":"Davis","year":"2006","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.clae.2015.08.002_bib0765","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1463-5224.2005.00422.x","article-title":"Ocular penetration of oral doxycycline in the horse","volume":"8","author":"Gilmour","year":"2005","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0770","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2133.1996.tb01170.x","article-title":"Minocycline-induced discolouration of the sclerae","volume":"135","author":"Sabroe","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0775","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0161-6420(97)30204-8","article-title":"Minocycline-induced scleral pigmentation","volume":"104","author":"Fraunfelder","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clae.2015.08.002_bib0780","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9394(99)80156-1","article-title":"Minocycline-induced scleral, dental and dermal pigmentation","volume":"125","author":"Morrow","year":"1998","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0785","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archopht.121.1.144","article-title":"Minocycline-induced ocular pigmentation","volume":"121","author":"Bradfield","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0790","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3129\/i07-084","article-title":"Scleral and conjunctival pigmentation following minocycline therapy","volume":"42","author":"McCallum","year":"2007","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0795","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.bdj.2013.682","article-title":"Feeling blue?. Minocycline-induced staining of the teeth, oral mucoas, scleare and ears \u2013 a case report","volume":"215","author":"Johnston","year":"2013","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.clae.2015.08.002_bib0800","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00105-014-3512-x","article-title":"Nebenwirkungen im Auge behalten","volume":"65","author":"Wirtz","year":"2014","journal-title":"Hautarzt"},{"key":"10.1016\/j.clae.2015.08.002_bib0805","first-page":"33","article-title":"A brown-eyed woman with blue discoloration of the sclera","volume":"72","author":"Bosma","year":"2014","journal-title":"Netherlands J. Med."},{"key":"10.1016\/j.clae.2015.08.002_bib0810","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/08820538.2011.631509","article-title":"Minocycline induced conjunctival autofluorescence deposition","volume":"27","author":"Lim","year":"2012","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0815","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin. Ther."},{"key":"10.1016\/j.clae.2015.08.002_bib0820","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/11319280-000000000-00000","article-title":"Minocycline in acne vulgaris","volume":"11","author":"Ochsendorf","year":"2010","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0825","first-page":"19","article-title":"Oral doxycycline in the management of acne vulgaris: Current perspectives on clinical use and recent findings with a new double-scored small tablet formulation","volume":"8","author":"Del Rosso","year":"2015","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0830","first-page":"1407","article-title":"Doxycycline and minocycline for the management of acne","volume":"11","author":"Kircik","year":"2010","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0835","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajo.2006.06.047","article-title":"Pediatric ocular rosacea: long term treatment with systemic antibiotics","volume":"142","author":"Cetinkaya","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0840","first-page":"853","article-title":"Drug interactions between oral contraceptives and antibiotics","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.clae.2015.08.002_bib0845","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0011-8532(02)00017-4","article-title":"Antibiotics and oral contraceptives","volume":"46","author":"De Rossi","year":"2002","journal-title":"Dent. Clin. North Am."},{"key":"10.1016\/j.clae.2015.08.002_bib0850","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mjd.2002.120448","article-title":"Oral contraceptive efficacy and antibiotic interactions: a myth debunked","volume":"46","author":"Archer","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0855","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1523\/JNEUROSCI.1733-14.2014","article-title":"LRP4 is critical for neuromuscular junction maintenance","volume":"34","author":"Barik","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clae.2015.08.002_bib0860","first-page":"303","article-title":"Effect of long term alcohol consumption on the half life of tetracycline and doxycycline in man","volume":"14","author":"Neuvonen","year":"1976","journal-title":"Int. J. Clin. Pharmacol."},{"key":"10.1016\/j.clae.2015.08.002_bib0865","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/bmj.1.5907.535","article-title":"Interaction between doxycycline and barbiturates","volume":"1","author":"Neuvonen","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.clae.2015.08.002_bib0870","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/bmj.2.5917.470","article-title":"Interaction between doxycycline and some antiepileptic drugs","volume":"2","author":"Pentill\u00e5","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.clae.2015.08.002_bib0875","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2230.2008.02904.x","article-title":"Drug interactions in dermatologial practice","volume":"33","author":"Tey","year":"2008","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0880","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/09273948.2013.801991","article-title":"Topical azithromycin as a novel treatment for ocular rosacea","volume":"21","author":"Mantelli","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.clae.2015.08.002_bib0885","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.1997.03890370055009","article-title":"Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline","volume":"133","author":"Quaterman","year":"1997","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.clae.2015.08.002_bib0890","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9394(14)71750-7","article-title":"Efficacy of doxycycline and tetracycline in ocular rosacea","volume":"116","author":"Frucht-Perry","year":"1993","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0895","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","article-title":"Topical azithromycin and oral doxycline therapy of Meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study","volume":"34","author":"Foulks","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.08.002_bib0900","first-page":"544","article-title":"Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline","volume":"8","author":"Arman","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0905","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3341\/kjo.2005.19.4.258","article-title":"The effect of low-dose doxycycline therapy in chronic Meibomian gland dysfunction","volume":"19","author":"Yoo","year":"2014","journal-title":"Korean J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0910","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/ICO.0000000000000051","article-title":"Treatment of ocular rosacea with once-daily low dose doxycycline","volume":"33","author":"Sobolewska","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.clae.2015.08.002_bib0915","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.2006.091579","article-title":"Short term oral minocycline treatment of meibomianitis","volume":"90","author":"Aronowicz","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0920","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","article-title":"Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe Meibomian gland dysfunction","volume":"154","author":"Lee","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0925","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bjo.2007.133900","article-title":"Changes in Meibomian fatty acids and clinical signs in patients with Meibomian gland dysfunction after minocycline treatment","volume":"92","author":"Souchier","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0930","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0014-4835(03)00005-8","article-title":"Minocycline effect on Meibomian gland lipids and in meibomianitis patients","volume":"76","author":"Shine","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.clae.2015.08.002_bib0935","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00417-008-1017-y","article-title":"The evaluation of the treatment response in obstructive Meibomian gland disease by in vivo laser confocal microscopy","volume":"247","author":"Matsumoto","year":"2009","journal-title":"Graefes Arch. Clin. Extl. Ophthalmol."},{"key":"10.1016\/j.clae.2015.08.002_bib0940","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00006324-200308000-00009","article-title":"A quantitative assessment of the location and width of Marx's line along the marginal zone of the human eyelid","volume":"80","author":"Donald","year":"2003","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.clae.2015.08.002_bib0945","unstructured":"Clinical Management Guidelines \u2018Blepharitis (inflammation of the lid margins). College of Optometrists, London, UK."},{"key":"10.1016\/j.clae.2015.08.002_bib0950","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bmj.39048.540394.BE","article-title":"Don\u2019t use minocycline as first line oral antibiotic in acne","volume":"33","author":"McMannus","year":"2007","journal-title":"BMJ"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048415300205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048415300205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T02:15:44Z","timestamp":1567131344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048415300205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1367048415300205"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2015.08.002","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the prescribing of oral doxycycline or minocycline by UK optometrists as part of management of chronic Meibomian Gland Dysfunction (MGD)","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}